ryvu.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://ryvu.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Home - Ryvu |
| Description | Developing therapeutics at the forefront of Ryvu Therapeutics is a clinical stage biopharmaceutical company developing novel small molecule therapies addressing high value emerging targets in precision |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.26.7.103 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
ryvu.com Valuation
|
US$3,377,888
Last updated: 2023-05-08 20:14:07
ryvu.com has Semrush global rank of 3,133,409. ryvu.com has an estimated worth of US$ 3,377,888, based on its estimated Ads revenue. ryvu.com receives approximately 389,757 unique visitors each day. Its web server is located in United States, with IP address 104.26.7.103. According to SiteAdvisor, ryvu.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,377,888 |
| Daily Ads Revenue | US$3,119 |
| Monthly Ads Revenue | US$93,542 |
| Yearly Ads Revenue | US$1,122,498 |
| Daily Unique Visitors | 25,984 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| ryvu.com. | A | 300 | IP: 104.26.7.103 |
| ryvu.com. | A | 300 | IP: 172.67.68.247 |
| ryvu.com. | A | 300 | IP: 104.26.6.103 |
| ryvu.com. | AAAA | 300 | IPV6: 2606:4700:20::681a:767 |
| ryvu.com. | AAAA | 300 | IPV6: 2606:4700:20::681a:667 |
| ryvu.com. | AAAA | 300 | IPV6: 2606:4700:20::ac43:44f7 |
| ryvu.com. | NS | 86400 | NS Record: lex.ns.cloudflare.com. |
| ryvu.com. | NS | 86400 | NS Record: mary.ns.cloudflare.com. |
| ryvu.com. | MX | 300 | MX Record: 0 ryvu-com.mail.protection.outlook.com. |
| ryvu.com. | TXT | 300 | TXT Record: v=verifydomain MS=8283039 |
| ryvu.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| ryvu.com. | TXT | 300 | TXT Record: google-site-verification=u_YFJcBhvO-jFs9cjKGO31uRDugHT8OkAa9ntXcpW7I |
HtmlToTextCheckTime:2023-05-08 20:14:07
| About Us Overview Managament Scientific Advisory Board Supervisory Board Collaborations Our Research Overview Clinical Projects Immunooncology Synthetic Lethality Collaborations Publications Pipeline Investors & Media Careers Why work with is Job Offers Meet the company About Cracow Benefits Recruitment Process Contact Us EN PL Developing therapeutics at the forefront of oncology About us News Releases Ryvu Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update Ryvu Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update Signed a collaboration agreement with BioNTech to develop and commercialize immunomodulatory small molecule therapeutics; deal terms included €20M upfront payment, €20M equity investment in Ryvu, research funding, and downstream milestones and royalties; Successfully completed a Public Offering, raising gross proceeds of $56M; Planning to advance RVU120 to Phase II in the |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 30 Oct 2021 15:50:09 GMT
Content-Type: text/html; charset=iso-8859-1
Connection: keep-alive
Location: https://ryvu.com/
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Ex1KqF6Z3q6ucbnUa8h9P%2FxHxEzlWiO81PMbt9fHRM2nL89PDVrvfiQJMkP9lJEKBKXUi7EOT2Yc%2BeTPjCdpOgUNBAeo8L8Cv1139Mi%2BRyRTEmnxKckkrRaf"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a65cc319d572ab6-ORD
HTTP/2 200
date: Sat, 30 Oct 2021 15:50:10 GMT
content-type: text/html; charset=UTF-8
x-powered-by: PHP/7.3.10
x-pingback: https://ryvu.com/xmlrpc.php
link:
|
ryvu.com Whois Information
Domain Name: RYVU.COM Registry Domain ID: 394121899_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-03-05T07:23:09Z Creation Date: 2006-03-31T05:14:54Z Registry Expiry Date: 2023-03-31T04:14:54Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: LEX.NS.CLOUDFLARE.COM Name Server: MARY.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T02:05:11Z <<< |